Not applicableNot Yet RecruitingNCT07008027What this trial is testingReal World Asparaginase Therapy ToxicityWho this might be right forDrug Toxicity St. Jude Children's Research Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06390319What this trial is testingAdding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)Who this might be right forT-cell Acute Lymphoblastic LeukemiaT-cell LymphomaMixed Phenotype Acute Leukemia St. Jude Children's Research Hospital 100
Early research (Phase 1)Ended earlyNCT00933985What this trial is testingObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forAcute Leukemias of Ambiguous LineageAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+26 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00732316What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Asan Medical Center 54
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Post-approval studies (Phase 4)Looking for participantsNCT06289673What this trial is testingIdentification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic LymphomaMixed Phenotype Acute Leukemia St. Jude Children's Research Hospital 850
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Early research (Phase 1)Study completedNCT00890747What this trial is testingSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT04195633What this trial is testingDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more Fred Hutchinson Cancer Center 60
Early research (Phase 1)Active Not RecruitingNCT04980404What this trial is testingInqovi Maintenance Therapy in Myeloid NeoplasmsWho this might be right forMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaStem Cell Leukemia Massachusetts General Hospital 22
Early research (Phase 1)Looking for participantsNCT04872478What this trial is testingPharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute Leukemia Meryx, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07222579What this trial is testingSubcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)Who this might be right forCD19 PositiveMixed Phenotype Acute Leukemia (MPAL) West Virginia University 78
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07517510What this trial is testingHVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).Who this might be right forNewly Diagnosed Mixed Phenotype Acute Leukemia (MPAL) Guangdong Second Provincial General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07216443What this trial is testingTrial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic SyndromesMixed Phenotype Acute Leukemia Orca Biosystems, Inc. 80
Not applicableAvailableNCT07346105What this trial is testingOrca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesWho this might be right forHematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoid Leukemia+2 more Orca Biosystems, Inc.
Not applicableLooking for participantsNCT01137825What this trial is testingRegistry of Older Patients With CancerWho this might be right forChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more UNC Lineberger Comprehensive Cancer Center 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03674411What this trial is testingTrial Evaluating MGTA-456 in Patients With High-Risk MalignancyWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaBiphenotypic/Undifferentiated Leukemia+8 more Masonic Cancer Center, University of Minnesota 22
Not applicableStudy completedNCT00014235What this trial is testingFludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more Fred Hutchinson Cancer Center 160
Testing effectiveness (Phase 2)Study completedNCT02728050What this trial is testingFilgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Biphenotypic LeukemiaAcute Myeloid Leukemiade Novo Myelodysplastic Syndrome+2 more University of Washington 84